首页|期刊导航|中国实验方剂学杂志|中医药调控相关信号通路防治乳腺癌及癌前病变研究进展

中医药调控相关信号通路防治乳腺癌及癌前病变研究进展OA

Traditional Chinese Medicine Regulates Related Signaling Pathways to Prevent and Control Breast Cancer and Precancerous Lesions:A Review

中文摘要英文摘要

乳腺癌已成为女性发病率最高的恶性肿瘤,严重威胁着全球女性的生命健康.乳腺癌的发病因素及发生发展机制复杂多样,乳腺细胞从普通型增生到非典型增生,从癌前病变发展为癌变,是一个长期渐进发展的过程.因此,乳腺癌的早期筛查及防治尤为重要.西医对于乳腺癌的治疗方案已相对成熟,以手术及全身治疗为主,但随之而来的并发症及不良反应常为患者带来沉重的负担;对乳腺癌癌前病变亦以手术治疗为主.近年来,中医药防治乳腺癌日渐凸显出其优势,越来越多的研究表明在乳腺癌及癌前病变的防治过程中,中药复方、单味中药或药对及其来源的中药单体化合物能够通过多靶点作用调控细胞内多种信号传导通路,可抑制肿瘤细胞增殖及侵袭,促进细胞凋亡及自噬,调控细胞周期及免疫微环境等,从而发挥抗肿瘤作用,同时还可显著减轻放化疗不良反应、降低患者耐药性等.然而,目前中医药防治乳腺癌及癌前病变的具体作用机制尚未完全明确,其通过调控乳腺癌磷脂酰肌醇3-激酶(PI3K)/蛋白激酶B(Akt)/哺乳动物雷帕霉素靶蛋白(mTOR)、Wnt/β-连环蛋白(β-catenin)、Notch等相关经典信号通路抑制肿瘤发生发展的研究报道纷繁复杂,仍需大量临床及实验研究进一步验证.因此,该文对近年来中医药通过干预相关信号通路,防治乳腺癌及癌前病变的国内外研究进展进行综述,以总结归纳中医药在乳腺癌防治中可能的作用机制,为后续研究提供参考.

Breast cancer has become the malignant tumor with the highest incidence rate among women,seriously threatening the life and health of women all over the world.The pathogenic factors and development mechanisms of breast cancer are complex and diverse.The development of breast cells from ordinary hyperplasia to atypical hyperplasia,and from pre-cancerous lesions to cancerous lesions,is a long-term progressive process.Therefore,early screening and prevention of breast cancer is particularly important.Western medicine has a relatively mature treatment program for breast cancer,which is mainly based on surgery and systemic treatment,whereas the ensuing complications and adverse reactions often bring a heavy burden to patients.For the precancerous lesions of breast cancer,surgery is also the mainstay of treatment.In recent years,traditional Chinese medicine(TCM)has increasingly highlighted its advantages in the prevention and treatment of breast cancer.Increasing studies have shown that in the prevention and treatment of breast cancer and pre-cancerous lesions,TCM compound prescriptions,single herbs or herb pairs,and active components are able to regulate a variety of intracellular signaling pathways through multi-targets to inhibit the proliferation and invasion,promote the apoptosis and autophagy of tumor cells,and regulate the cell cycle and the immune microenvironment,thus exerting anti-tumor effects.At the same time,they can significantly attenuate the toxic side effects of radiotherapy and drug resistance of patients.However,the specific mechanisms of TCM in the prevention and treatment of breast cancer and precancerous lesions have not been fully clarified.The available studies are tanglesome regarding the TCM inhibition of tumor development through the regulation of classical signaling pathways such as phosphatidylinositol 3-kinase(PI3K)/protein kinase B(Akt)/mammalian target of rapamycin(mTOR),Wnt/β-catenin,and Notch,which still need to be verified by a large number of clinical and experimental studies.Therefore,this paper reviews the research progress in the prevention and treatment of breast cancer and precancerous lesions by TCM through interfering with the relevant signaling pathways in recent years,aiming to summarize the possible mechanisms of TCM in the prevention and treatment of breast cancer and provide references for subsequent studies.

曾奕斐;赵迪;王君月;王梦洁;郭鱼波;周玉;张董晓;赵文洁

首都医科大学 附属北京中医医院,北京 100010||北京中医药大学,北京 100029首都医科大学 附属北京中医医院,北京 100010||北京中医药大学,北京 100029首都医科大学 附属北京中医医院,北京 100010||北京中医药大学,北京 100029首都医科大学 附属北京中医医院,北京 100010||北京中医药大学,北京 100029首都医科大学 附属北京中医医院,北京 100010首都医科大学 附属北京中医医院,北京 100010首都医科大学 附属北京中医医院,北京 100010首都医科大学 附属北京中医医院,北京 100010

医药卫生

乳腺癌癌前病变信号通路作用机制综述

breast cancerprecancerous lesionssignaling pathwaymechanismreview

《中国实验方剂学杂志》 2026 (5)

290-301,12

国家中医药管理局中医药古籍文献和特色技术传承专项(GZY-KJS-2022-035)世界中医药科技专项(WFCMS2024022)青年岐黄学者培养项目(2022年)北京市自然科学基金项目(7254493)北京市中医药科技发展资金项目(BJZYQN-2023-08)北京中医药大学教育科学研究课题(XJY24111)

10.13422/j.cnki.syfjx.20251128

评论